Global voices on atrial fibrillation: South/Southeast Asia

Rungroj Krittayaphong; Arintaya Phrommintikul; C.G. Bahuleyan; Rajendra Surenthirakumaran; Narayanan Namboodiri; Nayani Makkar; Jinbert Lordson; Antony Sheron Vethanayagam; Powsiga Uruthirakumar; Kumaran Subaschandran; Shribavan Kaneshamoorthy; Professor Gregory Lip

doi:10.1016/j.hroo.2024.06.004

Abstract

1 min read

Atrial fibrillation (AF) is a leading cause of mortality and morbidity worldwide.1,2 Despite the improvement in the rate of oral anticoagulant (OAC) use for stroke prevention, the residual risk of remain high.3,4 It is recommended that AF patients require a holistic care approach (ie, ABC [Atrial Fibrillation Better Care] pathway) to improve the outcomes.5–7

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal

Professor Gregory Lip, Marco Proietti, Tatjana Potpara, Moussa Mansour, Irina Savelieva, Hung‐Fat Tse, Andreas Goette, A. John Camm, Carina Blomström‐Lundqvist, Dhiraj Gupta, Giuseppe Boriani

Article2024

Atrial fibrillation: stroke prevention

Tze‐Fan Chao, Tatjana Potpara, Professor Gregory Lip

Article2024

Global voices on atrial fibrillation care in China

Mingfang Li, Minglong Chen, Yutao Guo, Professor Gregory Lip

Letter2021

Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the ‘transition era’ to non-vitamin K antagonist oral anticoagulants

Leona A. Ritchie, Deirdre A. Lane, Professor Gregory Lip

Article2024

Global voices on atrial fibrillation management: Brazil

Itamar S Santos, Alessandra C. Goulart, Paulo A. Lotufo, Kamila V Silva, Tiótrefis Gomes Fernandes, Thais M V Nascimento, Luís Marcelo Aranha Camargo, G. Neil Thomas, Professor Gregory Lip, Isabela M. Bensenor